Interim / Quarterly Report • Aug 25, 2022
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
of InVision AG as of 30 June 2022 in accordance with IFRS and § 315e of the German Commercial Code as well as the Group management report pursuant to § 315 of the German Commercial Code (condensed/unaudited)
Consolidated Balance Sheet Consolidated Statement of Comprehensive Income Consolidated Cash Flow Statement Consolidated Statement of Equity Consolidated Notes Interim Group Management Report Responsibility Statement by the Executive Board
| (in TEUR) | 6M 2022 | 6M 2021 | ∆* |
|---|---|---|---|
| injixo ARR (June) | 7,752 | 5,570 | +39% |
| Total Revenues | 7,092 | 6,768 | +5% |
| EBIT | -1,520 | 33 | -4,706% |
| as a % of revenues | -21% | 0% | -21 PP |
| Consolidated result | -1,935 | -327 | -492% |
| as a % of revenues | -27% | -5% | -22 PP |
| Operating cash flow | 1,155 | 1,591 | -27% |
| as a % of revenues | 16% | 24% | -8 PP |
| Earnings per share (in EUR) | -0.87 | -0.16 | -444% |
| (in TEUR) | 30 Jun 2022 | 31 Dec 2021 | ∆* |
|---|---|---|---|
| Balance sheet total | 23,378 | 19,988 | +17% |
| Liquid funds | 10,305 | 6,338 | +63% |
| Equity | 10,013 | 11,870 | -16% |
| as a % of balance sheet total | 43% | 59% | -16 PP |
The calculation of deviations from the previous year is based on non-rounded figures.
InVision AG, 30 June 2022 IFRS, in Euro (condensed/unaudited)
| Assets | 30 Jun 2022 | 31 Dec 2021 | |
|---|---|---|---|
| A. Short-term assets | |||
| 1. Liquid funds | 10,305,360 | 6,338,332 | |
| 2. Trade receivables | 1,500,570 | 1,309,512 | |
| 3. Income tax claims | 50,105 | 278,290 | |
| 4. Prepaid expenses and other short-term assets | 231,836 | 205,739 | |
| Total short-term assets | 12,087,871 | 8,131,873 | |
| B. Long-term assets | |||
| 1. Intangible assets | 265,907 | 274,921 | |
| 2. Tangible assets | 8,121,533 | 8,285,327 | |
| 3. Right-of-use assets | 1,133,771 | 1,179,547 | |
| 4. Deferred taxes | 1,758,643 | 2,103,983 | |
| 5. Other long-term assets | 9,981 | 12,050 | |
| Total long-term assets | 11,289,835 | 11,855,828 | |
| Total assets | 23,377,706 | 19,987,701 |
| Equity and liabilities | 30 Jun 2022 | 31 Dec 2021 | |
|---|---|---|---|
| A. Short-term liabilities | |||
| 1. Leasing liabilities | 198,005 | 188,698 | |
| 2. Trade payables | 254,716 | 151,519 | |
| 3. Provisions | 176,845 | 203,680 | |
| 4. Income tax liabilities | 155,130 | 173,492 | |
| 5. Customer contract liabilities and other liabilities | 3,492,413 | 1,256,011 | |
| Total short-term liabilities | 4,277,109 | 1,973,400 | |
| B. Long-term liabilities | |||
| 1. Liabilities due to credit institutions | 8,040,000 | 5,040,000 | |
| 2. Leasing liabilities | 1,047,910 | 1,104,125 | |
| Total long-term liabilities | 9,087,910 | 6,144,125 | |
| C. Equity | |||
| 1. Subscribed capital | 2,235,000 | 2,235,000 | |
| 2. Reserves | 1,281,831 | 1,204,142 | |
| 3. Equity capital difference from currency translation |
-404,903 | -408,788 | |
| 4. Group/consolidated result | 6,900,759 | 8,839,822 | |
| Total equity | 10,012,687 | 11,870,176 | |
| Total equity and liabilities | 23,377,706 | 19,987,701 |
4
| 1 Jan - 30 Jun 2022 | 1 Jan - 30 Jun 2021 | |
|---|---|---|
| 1. Revenues | 7,092,086 | 6,767,554 |
| 2. Other operating income | 29,206 | 14,952 |
| 3. Cost of materials/cost of goods and services purchased |
0 | -2,975 |
| 4. Personnel expenses | -6,322,763 | -4,902,535 |
| 5. Amortisation/depreciation of intangible and tangible assets |
-355,115 | -356,765 |
| 6. Other operating expenses | -1,963,078 | -1,487,100 |
| 7. Operating result (EBIT) | -1,519,664 | 33,131 |
| 8. Financial result | -49,885 | -48,689 |
| 9. Currency losses/gains | -8,700 | -4,215 |
| 10. Result before taxes (EBT) | -1,578,249 | -19,773 |
| 11. Income tax | -360,814 | -342,820 |
| 12. Consolidated net loss/profit | -1,939,063 | -362,593 |
| 13. Exchange rate differences from converting foreign financial statements |
3,885 | 35,568 |
| 14. Consolidated result | -1,935,178 | -327,025 |
| Earnings per share | -0.87 | -0.16 |
InVision AG, 30 June 2022 IFRS, in Euro (condensed/unaudited)
| 1 Jan - 30 Jun 2022 | 1 Jan - 30 Jun 2021 | |
|---|---|---|
| 1. Cash flow from operating activities | ||
| Consolidated result | -1,939,063 | -362,593 |
| + Depreciation and amortisation of fixed assets |
355,115 | 356,765 |
| Profits(-)/losses(+) from the disposal of intangible and tangible assets |
-3,083 | -4,938 |
| Decrease(-)/increase(+) in provisions | -26,835 | -59,916 |
| Increase(-)/decrease(+) in deferred taxes | 345,340 | 344,595 |
| Other non-cash income(-)/expenses(+) | 89,403 | 8,655 |
| Increase(-)/decrease(+) in trade receivables |
-191,058 | -584,415 |
| Increase(-)/decrease(+) in other assets and prepaid expenses |
-24,028 | -42,973 |
| Decrease(-)/increase(+) in income tax liabilities/claims (netted) |
209,823 | -533,654 |
| Decrease(-)/increase(+) in trade payables |
103,197 | 187,248 |
| Decrease(-)/increase(+) in other liabilities and customer contract liabilities |
2,236,402 | 2,282,015 |
| Cash flow from operating activities | 1,155,213 | 1,590,789 |
| 1 Jan - 30 Jun 2022 | 1 Jan - 30 Jun 2021 | |
|---|---|---|
| 2. Cash flow from investing activities | ||
| - Payments made for investments in tangible assets |
-63,816 | -107,781 |
| - Payments made for investments in intangible assets |
-6,000 | -60,627 |
| + Payments received from the disposal of intangible and tangible assets |
3,083 | 4,938 |
| Cash flow from investing activities | -66,733 | -163,470 |
| 3. Cash flow from financing activities | ||
| + Additions to long-term financing liabilities |
3,000,000 | 0 |
| - Payments made for redemption of long term financing liabilities |
0 | -480,000 |
| - Payments made for redemption of lease liabilities |
-98,098 | -92,799 |
| Cash flow from financing activities | 2,901,902 | -572,799 |
| Change in cash and cash equivalents | 3,990,382 | 854,520 |
| Effect of foreign exchange rate changes on cash and cash equivalents |
-23,354 | 20,008 |
| Cash and cash equivalents at the beginning of the period |
6,338,332 | 7,790,641 |
| Cash and cash equivalents at the end of the period |
10,305,360 | 8,665,169 |
InVision AG, 30 June 2022 IFRS, in Euro (condensed/unaudited)
| Subscribed capital | Reserves | Equity capital difference from currency translation |
Profit/Losses | Equity | |
|---|---|---|---|---|---|
| 31 December 2020 |
2,235,000 | 1,191,184 | -486,974 | 10,473,881 | 13,413,091 |
| Consolidated net profit |
0 | 0 | 0 | -1,634,059 | -1,634,059 |
| Exchange rate difference from converting foreign financial statements |
0 | 0 | 78,186 | 0 | 78,186 |
| Total of costs and income |
0 | 0 | 78,186 | -1,634,059 | -1,555,873 |
| Stock option plan |
0 | 12,958 | 0 | 0 | 12,958 |
| 31 December 2021 |
2,235,000 | 1,204,142 | -408,788 | 8,839,822 | 11,870,176 |
| Consolidated net profit |
0 | 0 | 0 | -1,939,063 | -1,939,063 |
| Exchange rate difference from converting foreign financial statements |
0 | 0 | 3,885 | 0 | 3,885 |
| Total of costs and income |
0 | 0 | 3,885 | -1,939,063 | -1,935,178 |
| Stock option plan |
0 | 77,689 | 0 | 0 | 77,689 |
| 30 June 2022 |
2,235,000 | 1,281,831 | -404,903 | 6,900,759 | 10,012,687 |
to the Consolidated Interim Financial Statements of InVision AG as of 30 June 2022 (condensed/unaudited)
InVision Aktiengesellschaft, Düsseldorf (hereinafter also referred to as "InVision AG" or the "Company"), together with its subsidiaries (hereinafter also referred to as the "InVision Group" or the "Group"), develops and markets products and services in the field of workforce management and education, and is mainly active in Europe and the United States.
The Company's registered offices are located at Speditionstraße 5, 40221 Düsseldorf, Germany. It is recorded in the Commercial Register of the Local Court of Düsseldorf under registration number HRB 44338. InVision AG has been listed in the prime standard segment of the Frankfurt Stock Exchange under securities identification number 585969 since 18 June 2007.
The condensed consolidated interim financial report for the reporting period was prepared in accordance with IAS 34 "Interim Financial Reporting". The condensed consolidated interim financial report does not contain all explanations and information that are required for the financial statements of the full fiscal year and should be read in conjunction with the consolidated financial statements as of 31 December of the previous fiscal year.
The group of consolidated companies has not changed since 31 December of the previous fiscal year.
The Company has no treasury shares.
Revenues are categorised as follows:
| By Regions (in TEUR) | 6M 2022 | 6M 2021 |
|---|---|---|
| Germany | 3,216 | 2,714 |
| Foreign countries | 3,876 | 4,054 |
| Total | 7,092 | 6,768 |
The breakdown of revenues by region is based on the location of the company recording the revenues.
After the end of the reporting period, there were no specific events which were of significant importance for the interim financial report.
The Executive Board is composed of the following members:
Peter Bollenbeck, Düsseldorf
Earnings per share were calculated by dividing the periodic result, which is attributable to InVision AG's shareholders, by the average weighted number of shares issued and outstanding during the reporting period. InVision AG has issued only ordinary shares. In the first six months of 2022, there was an average of 2,235,000 shares issued and outstanding. Therefore, earnings per share for this period were EUR -0.87, compared to EUR -0.16 in the previous year, based on 2,235,000 shares issued.
Düsseldorf, 25 August 2022
Peter Bollenbeck
of InVision AG as of 30 June 2022 pursuant to §315 of the German Commercial Code (condensed/unaudited)
At the end of the first half-year of 2022 the injixo ARR increased by 39 percent to TEUR 7,752 (previous year: TEUR 5,570). Consolidated revenues increased by 5 percent to TEUR 7,092 in the reporting period (previous year: TEUR 6,768). Personnel expenses went up by 29 percent to TEUR 6,323 in the reporting period (previous year: TEUR 4,903). Other operating expenses increased by 32 percent to TEUR 1,963 in the reporting period (previous year: TEUR 1,487). The operating result (EBIT) decreased in the reporting period to TEUR -1.520 (previous year: TEUR 33). The EBIT margin in the first half of the year was -21 percent (previous year: 0 percent). In the reporting period, the consolidated result equalled TEUR -1.935 (previous year: TEUR -327). Earnings per share were EUR -0.87 (previous year: EUR -0.16), based on an average of 2,235,000 shares (previous year: 2,235,000 shares).
Cash flow from operating activities reached TEUR 1,155 in the reporting period (previous year: TEUR 1,591), which corresponds to a share of 16 percent of the Group revenues (previous year: 24 percent). As of the end of the reporting period, liquid funds (cash) increased to TEUR 10,305 (31 December 2021: TEUR 6,338). The balance sheet total equalled TEUR 23,378 (31 December 2021: TEUR 19,988), as of the end of the reporting period. Equity capital is now at TEUR 10,013 (31 December 2021: TEUR 11,870), and the equity ratio equals 43 percent (31 December 2021: 59 percent).
Reasonable opportunities for the business development of the InVision Group are described in the forecast report of this interim Group management report and in the Group management report of the previous fiscal year. The risks are described in the Group management report for the previous fiscal year.
After the end of the reporting period, there were no specific events which were of significant importance for the interim financial report.
In addition to the forecast published in the Group management report as of 31 December 2021, we expect group revenues of EUR 14 million to EUR 14.5 million for the 2022 fiscal year (previously: above prior-year level) and an EBIT of minus EUR 3.5 million to minus EUR 4 million (previously: up to minus EUR 5 million). Due to increased forecast uncertainty, we are currently unable to confirm the originally announced growth of the injixo ARR of at least 40 percent. We expect to be able to make a sufficiently reliable forecast of the injixo ARR for the end of the year with the publication of the 9-month report 2022.
For the following years, we continue to expect a sustainable growth of the injixo ARR at a high level and a successive improvement in EBIT. In 2025, we still project total revenues of EUR 50 million and an EBIT margin of 25 percent.
We also continue to reserve the right to review options for a capital increase for further growth financing in the course of 2022.
Düsseldorf, 25 August 2022
The Executive Board
Peter Bollenbeck
To the best of our knowledge and in accordance with the applicable reporting principles for financial reporting, the consolidated interim financial statements give a true and fair view of the Group's assets, liabilities, financial position, and results of operation, and the interim Group's management report includes a fair review of the development and performance of the business, together with a description of the principal opportunities and risks related to the anticipated development of the Group for the remainder of the fiscal year
Düsseldorf, 25 August 2022
The Executive Board
Peter Bollenbeck
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.